Log in to save to my catalogue

Homologous recombination deficiency status-based classification of high-grade serous ovarian carcino...

Homologous recombination deficiency status-based classification of high-grade serous ovarian carcino...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7026096

Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma

About this item

Full title

Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2020-02, Vol.10 (1), p.2757-2757, Article 2757

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Homologous recombination repair (HRR) pathway deficiency (HRD) is involved in the tumorigenesis and progression of high-grade serous ovarian carcinoma (HGSOC) as well as in the sensitivity to platinum chemotherapy drugs. In this study, we obtained data from The Cancer Genome Atlas (TCGA) on HGSOC and identified scores for the loss of heterozygosity...

Alternative Titles

Full title

Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7026096

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7026096

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-020-59671-3

How to access this item